Allscripts Reports Fiscal 2009 Third Quart...(gin percentage was 52.5% for the first n...),Health

Net income for the nine months ended February 28, 2009 was $12.7 million compared to net income of $14.5 million, for the same period last year. Earnings for the nine months ended February 28, 2009 were 11 cents per share.

Non-GAAP net income for the nine months ended February 28, 2009 was $54.5 million compared to non-GAAP net income of $43.5 million for the same period last year, representing an increase of 25%. Non-GAAP net income for the nine months ended February 28, 2009 and February 29, 2008 is comprised of net income giving effect to the add-back of Allscripts net income for respective periods prior to the consummation date of the merger of $6.7 million and $9.5 million, respectively, net of tax; acquisition-related amortization of $8.8 million and $11.8 million, respectively, net of tax; total stock-based compensation expense of $3.5 million and $4.3 million, respectively, net of tax; and transaction-related expenses of $19.6 million and $5.5 million, net of tax. Non-GAAP net income for the nine months ended February 28, 2009 also gives effect to the deferred revenue adjustment of $3.2 million, net of tax. Non-GAAP net income for the nine months ended February 29, 2008 gives effect to the tax adjustment of ($2.1) million, net of tax. Non-GAAP earnings for the nine months ended February 28, 2009 were 46 cents per share.

Conference Call

Allscripts will conduct a conference call on Thursday, April 2, 2009 at 4:30 PM Eastern Time. The conference call can be accessed via the Internet at www.allscripts.com, or by dialing (800) 374-1376 and requesting the Allscripts investor presentation. International callers can access the audio portion of the webcast by dialing (706) 679-4010 and requesting the Allscripts inves
'/>"/>

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health